CCND1 and non-small cell lung carcinoma: In addition, increased cyclin D1 expression has been reported in pancreatic, colorectal, head and neck squamous cell, as well as endometrial carcinoma and NSCLC [12,33], while cyclin D1 overexpression or amplification is frequently found in breast cancer [33,50,51].